An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

This study was a multicenter, prospective, non-interventional, observational study of factors affecting blood pressure and blood lipids after treatment with Amosartan Q tablet in hypertension patients with dyslipidemia. Data was collected from patients receiving routine treatment at hospitals in South Korea. Each patient visited the institution according to the protocol that designed the follow-up visits for six months to examine the effectiveness and safety of Amosartan Q tablet. This study approved by the institutions' IRBs and was conducted in compliance with clinical research ethics regulations.